Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.92 USD | -0.11% | -15.61% | +12.06% |
Apr. 24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
Apr. 24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 991M |
---|---|---|---|---|---|
Net income 2024 * | -195M | Net income 2025 * | -209M | EV / Sales 2024 * | - |
Net cash position 2024 * | 92.93M | Net cash position 2025 * | 93.52M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.9
x | P/E ratio 2025 * |
-5.15
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.4% |
Latest transcript on Centessa Pharmaceuticals plc
1 day | -0.11% | ||
1 week | -15.61% | ||
Current month | -21.06% | ||
1 month | -17.10% | ||
3 months | +9.99% | ||
6 months | +31.37% | ||
Current year | +12.06% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 20-12-31 |
Director of Finance/CFO | 53 | 21-02-28 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 21-02-22 | |
Chairman | 54 | 20-10-31 | |
Brett Zbar
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.92 | -0.11% | 254,924 |
24-04-25 | 8.93 | -5.60% | 286,596 |
24-04-24 | 9.46 | +0.64% | 2,251,501 |
24-04-23 | 9.4 | -6.00% | 200,077 |
24-04-22 | 10 | -5.39% | 210,810 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.06% | 991M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CNTA Stock